Showing results (11-20 of 111) with videos related to

Sort By:
Pageof 12
Current Medical Research and Opinion|April 7, 2005
The effect of bosentan on matrix metalloproteinase-9 levels in patients with systemic sclerosis-induced pulmonary hypertensionGianluigi Giannelli, Florenzo Iannone, Felice Marinosci, et al.
Autoimmunity Reviews|January 26, 2016
Impact of obesity on the clinical outcome of rheumatologic patients in biotherapyFlorenzo Iannone, Giuseppe Lopalco, Donato Rigante, et al.
Clinica Chimica Acta; International Journal of Clinical Chemistry|April 12, 2005
Anti-cyclic citrullinated peptide autoantibodies measured by an automated enzyme immunoassay: analytical performance and clinical correlationsMarilina Tampoia, Vincenzo Brescia, Antonietta Fontana, et al.
The Journal of Rheumatology|September 9, 2006
Use of etanercept in the treatment of dermatomyositis: a case seriesFlorenzo Iannone, Crescenzio Scioscia, Paola C F Falappone, et al.
Autoimmunity Reviews|March 25, 2014
The use of biosimilars in immune-mediated disease: A joint Italian Society of Rheumatology (SIR), Italian Society of Dermatology (SIDeMaST), and Italian Group of Inflammatory Bowel Disease (IG-IBD) position paperGionata Fiorino, Giampiero Girolomoni, Giovanni Lapadula, et al.
Clinical Rheumatology|January 22, 2014
Early-onset sarcoidosis caused by a rare CARD15/NOD2 de novo mutation and responsive to infliximab: a case report with long-term follow-up and review of the literatureFrancesco La Torre, Giovanni Lapadula, Luca Cantarini, et al.
The Journal of Rheumatology|January 17, 2014
Safety of etanercept and methotrexate in patients with rheumatoid arthritis and hepatitis C virus infection: a multicenter randomized clinical trialFlorenzo Iannone, Giovanni La Montagna, Gianfilippo Bagnato, et al.
Joint Bone Spine|April 28, 2016
Early clinical response predicts low disease activity at one year in rheumatoid arthritis patients on treatment with certolizumab in real-life settings. An appraisal of the Italian registry GISEAFlorenzo Iannone, Giorgio Carlino, Antonio Marchesoni, et al.
Joint Bone Spine|January 27, 2015
Obesity reduces the drug survival of second line biological drugs following a first TNF-α inhibitor in rheumatoid arthritis patientsFlorenzo Iannone, Rosalinda Fanizzi, Antonella Notarnicola, et al.
Clinical and Experimental Rheumatology|January 29, 2011
Intentional etanercept use during pregnancy for maintenance of remission in rheumatoid arthritisCrescenzio Scioscia, Marco Scioscia, Maria Grazia Anelli, et al.
Pageof 12